BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 15288581)

  • 1. Reversal of delta 9-tetrahydrocannabinol-induced tolerance by specific kinase inhibitors.
    Bass CE; Welch SP; Martin BR
    Eur J Pharmacol; 2004 Aug; 496(1-3):99-108. PubMed ID: 15288581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of several kinases in mice tolerant to delta 9-tetrahydrocannabinol.
    Lee MC; Smith FL; Stevens DL; Welch SP
    J Pharmacol Exp Ther; 2003 May; 305(2):593-9. PubMed ID: 12606657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic Delta9-tetrahydrocannabinol treatment produces antinociceptive tolerance in mice without altering protein kinase A activity in mouse brain and spinal cord.
    Dalton GD; Smith FL; Smith PA; Dewey WL
    Biochem Pharmacol; 2005 Jul; 70(1):152-60. PubMed ID: 15913565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ras/ERK signalling in cannabinoid tolerance: from behaviour to cellular aspects.
    Rubino T; Forlani G; Viganò D; Zippel R; Parolaro D
    J Neurochem; 2005 May; 93(4):984-91. PubMed ID: 15857401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic treatment with Delta(9)-tetrahydrocannabinol impairs spatial memory and reduces zif268 expression in the mouse forebrain.
    Boucher AA; Vivier L; Metna-Laurent M; Brayda-Bruno L; Mons N; Arnold JC; Micheau J
    Behav Pharmacol; 2009 Feb; 20(1):45-55. PubMed ID: 19179850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerance to the reinforcing effects of morphine in delta9-tetrahydrocannabinol treated mice.
    Jardinaud F; Roques BP; Noble F
    Behav Brain Res; 2006 Oct; 173(2):255-61. PubMed ID: 16884789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of morphine antinociceptive tolerance and dependence by the acute supraspinal inhibition of Ca(2+)/calmodulin-dependent protein kinase II.
    Tang L; Shukla PK; Wang LX; Wang ZJ
    J Pharmacol Exp Ther; 2006 May; 317(2):901-9. PubMed ID: 16505162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. delta9-Tetrahydrocannabinol: tolerance after noncontingent exposure in rats.
    Järbe TU
    Arch Int Pharmacodyn Ther; 1978 Jan; 231(1):49-56. PubMed ID: 637625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in brain Protein Kinase A activity and reversal of morphine tolerance by two fragments of native Protein Kinase A inhibitor peptide (PKI).
    Dalton GD; Smith FL; Smith PA; Dewey WL
    Neuropharmacology; 2005 Apr; 48(5):648-57. PubMed ID: 15814100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation: a molecular switch in opioid tolerance.
    Wang ZJ; Wang LX
    Life Sci; 2006 Sep; 79(18):1681-91. PubMed ID: 16831450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1.
    Ramer R; Hinz B
    J Natl Cancer Inst; 2008 Jan; 100(1):59-69. PubMed ID: 18159069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral cross-tolerance between repeated intracerebellar nicotine and acute Delta(9)-tetrahydrocannabinol-induced cerebellar ataxia: role of cerebellar nitric oxide.
    Smith AD; Dar MS
    J Pharmacol Exp Ther; 2007 Jul; 322(1):243-53. PubMed ID: 17416741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delta9-tetrahydrocannabinol-induced apoptosis in Jurkat leukemia T cells is regulated by translocation of Bad to mitochondria.
    Jia W; Hegde VL; Singh NP; Sisco D; Grant S; Nagarkatti M; Nagarkatti PS
    Mol Cancer Res; 2006 Aug; 4(8):549-62. PubMed ID: 16908594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
    Hayakawa K; Mishima K; Hazekawa M; Sano K; Irie K; Orito K; Egawa T; Kitamura Y; Uchida N; Nishimura R; Egashira N; Iwasaki K; Fujiwara M
    Brain Res; 2008 Jan; 1188():157-64. PubMed ID: 18021759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gonadal hormone modulation of the behavioral effects of Delta9-tetrahydrocannabinol in male and female rats.
    Craft RM; Leitl MD
    Eur J Pharmacol; 2008 Jan; 578(1):37-42. PubMed ID: 17905227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic adenosine 3',5'monophosphate/protein kinase A and mitogen-activated protein kinase 3/1 pathways are involved in adenylate cyclase-activating polypeptide 1-induced common alpha-glycoprotein subunit gene (Cga) expression in mouse pituitary gonadotroph LbetaT2 cells.
    Harada T; Kanasaki H; Mutiara S; Oride A; Miyazaki K
    Biol Reprod; 2007 Oct; 77(4):707-16. PubMed ID: 17596563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase C can inhibit TRPC3 channels indirectly via stimulating protein kinase G.
    Kwan HY; Huang Y; Yao X
    J Cell Physiol; 2006 May; 207(2):315-21. PubMed ID: 16331690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delta9-Tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo.
    Preet A; Ganju RK; Groopman JE
    Oncogene; 2008 Jan; 27(3):339-46. PubMed ID: 17621270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose and behavioral context dependent inhibition of movement and basal ganglia neural activity by Delta-9-tetrahydrocannabinol during spontaneous and treadmill locomotion tasks in rats.
    Shi LH; Luo F; Woodward DJ; Chang JY
    Synapse; 2005 Jan; 55(1):1-16. PubMed ID: 15499609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of the role of conventional, novel and atypical PKC isoforms in the expression of morphine tolerance in mice.
    Smith FL; Gabra BH; Smith PA; Redwood MC; Dewey WL
    Pain; 2007 Jan; 127(1-2):129-39. PubMed ID: 16965856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.